Center for Scientific Review; Notice of Closed Meetings, 25135-25136 [2014-10016]

Download as PDF Federal Register / Vol. 79, No. 85 / Friday, May 2, 2014 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. mstockstill on DSK4VPTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Gene Therapy. Date: May 16, 2014. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Dominique Lorang-Leins, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Room 5108, MSC 7766, Bethesda, MD 20892, 301.326.9721, Lorangd@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Auditory Neuroscience. Date: May 27–28, 2014. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: John Bishop, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408– 9664, bishopj@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 28, 2014. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2014–10017 Filed 5–1–14; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 00:23 May 02, 2014 Jkt 232001 Name of Committee: Center for Scientific Review Special Emphasis Panel; NHLBI Systems Biology. Date: May 27–28, 2014. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD 20892, 301–408– 9497, zouai@csr.nih.gov. Name of Committee: Cardiovascular and Respiratory Sciences Integrated Review Group; Lung Injury, Repair, and Remodeling Study Section. Date: June 2, 2014. Time: 7:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Guest Suites Santa Monica, 1707 Fourth Street, Santa Monica, CA 90401. Contact Person: Ghenima Dirami, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4122, MSC 7814, Bethesda, MD 20892, 240–498– 7546, diramig@csr.nih.gov. Name of Committee: Risk, Prevention and Health Behavior Integrated Review Group; Psychosocial Risk and Disease Prevention Study Section. Date: June 2–3, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Stacey FitzSimmons, Ph.D., MPH, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3114, PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 25135 MSC 7808, Bethesda, MD 20892, 301–451– 9956, fitzsimmonss@csr.nih.gov. Name of Committee: Risk, Prevention and Health Behavior Integrated Review Group;, Behavioral Medicine, Interventions and Outcomes Study Section. Date: June 2–3, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Loews Annapolis Hotel, 126 West Street, Annapolis, MD 21401. Contact Person: Lee S Mann, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3186, MSC 7848, Bethesda, MD 20892, 301–435– 0677, mannl@csr.nih.gov. Name of Committee: Digestive, Kidney and Urological Systems Integrated Review Group; Clinical, Integrative and Molecular Gastroenterology Study Section. Date: June 2, 2014. Time: 8:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Raleigh Durham Airport, @ Research Triangle Park, 4810 Page Creek Lane, Durham,, NC 27703. Contact Person: Mushtaq A Khan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2176, MSC 7818, Bethesda, MD 20892, 301–435– 1778, khanm@csr.nih.gov. Name of Committee: Surgical Sciences, Biomedical Imaging and Bioengineering Integrated Review Group; Bioengineering, Technology and Surgical Sciences Study Section. Date: June 2–3, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Long Beach Hotel, 111 East Ocean Blvd., Long Beach, CA 90802. Contact Person: Khalid Masood, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5120, MSC 7854, Bethesda, MD 20892, 301–435– 2392, masoodk@csr.nih.gov. Name of Committee: Cell Biology Integrated Review Group; Development—2 Study Section. Date: June 2–3, 2014. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Long Beach Hotel, 111 East Ocean Blvd., Long Beach, CA 90802. Contact Person: Rass M Shayiq, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institute of Health, 6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD 20892, (301) 435– 2359, shayiqr@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Psychosocial Risk and Disease Prevention. Date: June 2, 2014. Time: 11:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\02MYN1.SGM 02MYN1 25136 Federal Register / Vol. 79, No. 85 / Friday, May 2, 2014 / Notices Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Kristen Prentice, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3112, MSC 7808, Bethesda, MD 20892, 301–496– 0726, prenticekj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 28, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–10016 Filed 5–1–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Interagency Coordinating Committee on the Validation of Alternative Methods; Notice of Public Meeting; Request for Public Input The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) will hold a public forum to share information and facilitate direct communication of ideas and suggestions from stakeholders. Interested persons may attend in person or via teleconference and time will be set aside for public statements and questions on the topics discussed. DATES: Meeting: June 25, 2014, 1:00 p.m. to approximately 4:00 p.m. Eastern Daylight Time (EDT). Registration for Meeting: May 7, 2014 through June 11, 2014. Deadline for Submission of Oral Public Statements: June 11, 2014 ADDRESSES: Meeting Location: William H. Natcher Conference Center, National Institutes of Health, Bethesda, MD 20892. Meeting Web page: The preliminary agenda, registration, and other meeting materials are at https://ntp.niehs.nih.gov/ go/41490. FOR FURTHER INFORMATION CONTACT: Dr. Warren S. Casey, Director, National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM); email: warren.casey@nih.gov; telephone: (919) 316–4729. SUPPLEMENTARY INFORMATION: Background: ICCVAM promotes the development and validation of chemical safety testing methods that protect mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 00:23 May 02, 2014 Jkt 232001 human health and the environment while replacing, reducing, or refining animal use. In 2013, ICCVAM published a draft plan (https://ntp.niehs.nih.gov/go/ iccvam-mission) focused on addressing advances in toxicological science while reflecting the needs and priorities of its partner regulatory agencies and improving communications with the public, including holding public forums to facilitate direct communication with its stakeholders. The first of these forums will be held on June 25, 2014, at the National Institutes of Health in Bethesda, MD. The meeting will begin with presentations by NICEATM and ICCVAM members on current activities including (1) evaluation of nonanimal methods to identify potential skin sensitizers and eye irritants, (2) interactions with international validation organizations, and (3) revisions to ICCVAM processes. Following each presentation, there will be an opportunity for attendees to ask questions. The agenda also includes time for attendees to make public oral statements to inform ICCVAM on topics relevant to its mission and current activities. Preliminary Agenda and Other Meeting Information: The preliminary agenda, ICCVAM roster, background materials, and public statements submitted prior to the meeting will be posted at https://ntp.niehs.nih.gov/go/ 41490 to allow participation by remote attendees. Public statements will be distributed to NICEATM and ICCVAM members. Meeting and Registration: This meeting is open to the public with time scheduled for oral public statements and for questions following ICCVAM’s and NICEATM’s presentations; attendance is limited only by the space available. Participants are encouraged to register at https://ntp.niehs.nih.gov/go/ 41490 by June 11, 2014 to facilitate planning for appropriate meeting space. Interested individuals are encouraged to visit this Web page to stay abreast of the most current meeting information. Visitor and security information is available at https://www.nih.gov/about/ visitor/index.htm. Individuals with disabilities who need accommodation to participate in this event should contact Dr. Elizabeth Maull at phone: (919) 316– 4668 or email: maull@niehs.nih.gov. TTY users should contact the Federal TTY Relay Service at 800–877–8339. Requests should be made at least five business days in advance of the event. Request for Oral Public Statements: Time will be allotted during the meeting for oral public statements with PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 associated slides relevant to ICCVAM’s mission and current activities. The number and length of presentations may be limited based on available time. Speakers are asked to submit a copy of their statement and/or associated slides by June 11, 2014 to allow time for posting to the meeting page and review by NICEATM and ICCVAM members. Submitters will be identified by their name and affiliation and/or sponsoring organization, if applicable. Persons submitting public statements and/or associated slides should include their name, affiliation (if any), mailing address, telephone, email, and sponsoring organization (if any) with the document. Registration for oral public statements will be available onsite, although onsite registration and time allotted for these statements may be limited based on the number of individuals who register for comments and available time. For remote participation, 50 teleconference lines will be available on a first-come, first-served basis. The teleconference access number will be provided to registrants by email prior to the meeting. Responses to this notice are voluntary. No proprietary, classified, confidential, or sensitive information should be included in comments submitted in response to this notice or during the meeting. This request for input is for planning purposes only and is not a solicitation for applications or an obligation on the part of the U.S. Government to provide support for any ideas identified in response to the request. Please note that the U.S. Government will not pay for the preparation of any information submitted or for its use of that information. Background Information on ICCVAM and NICEATM: ICCVAM is an interagency committee composed of representatives from 15 Federal regulatory and research agencies that require, use, generate, or disseminate toxicological and safety testing information. ICCVAM conducts technical evaluations of new, revised, and alternative safety testing methods and integrated testing strategies with regulatory applicability and promotes the scientific validation and regulatory acceptance of testing methods that both more accurately assess the safety and hazards of chemicals and products and replace, reduce, or refine (enhance animal well-being and lessen or avoid pain and distress) animal use. The ICCVAM Authorization Act of 2000 (42 U.S.C. 285l–3) establishes ICCVAM as a permanent interagency committee of the NIEHS and provides E:\FR\FM\02MYN1.SGM 02MYN1

Agencies

[Federal Register Volume 79, Number 85 (Friday, May 2, 2014)]
[Notices]
[Pages 25135-25136]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-10016]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; NHLBI Systems Biology.
    Date: May 27-28, 2014.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD 
20892, 301-408-9497, zouai@csr.nih.gov.

    Name of Committee: Cardiovascular and Respiratory Sciences 
Integrated Review Group; Lung Injury, Repair, and Remodeling Study 
Section.
    Date: June 2, 2014.
    Time: 7:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Guest Suites Santa Monica, 1707 Fourth Street, 
Santa Monica, CA 90401.
    Contact Person: Ghenima Dirami, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4122, MSC 7814, Bethesda, MD 
20892, 240-498-7546, diramig@csr.nih.gov.

    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group; Psychosocial Risk and Disease Prevention 
Study Section.
    Date: June 2-3, 2014.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Stacey FitzSimmons, Ph.D., MPH, Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3114, MSC 7808, Bethesda, MD 
20892, 301-451-9956, fitzsimmonss@csr.nih.gov.

    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group;, Behavioral Medicine, Interventions and 
Outcomes Study Section.
    Date: June 2-3, 2014.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Loews Annapolis Hotel, 126 West Street, Annapolis, MD 
21401.
    Contact Person: Lee S Mann, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3186, MSC 7848, Bethesda, MD 20892, 301-435-
0677, mannl@csr.nih.gov.

    Name of Committee: Digestive, Kidney and Urological Systems 
Integrated Review Group; Clinical, Integrative and Molecular 
Gastroenterology Study Section.
    Date: June 2, 2014.
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Raleigh Durham Airport, @ Research Triangle Park, 
4810 Page Creek Lane, Durham,, NC 27703.
    Contact Person: Mushtaq A Khan, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 2176, MSC 7818, Bethesda, MD 
20892, 301-435-1778, khanm@csr.nih.gov.

    Name of Committee: Surgical Sciences, Biomedical Imaging and 
Bioengineering Integrated Review Group; Bioengineering, Technology 
and Surgical Sciences Study Section.
    Date: June 2-3, 2014.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Renaissance Long Beach Hotel, 111 East Ocean Blvd., Long 
Beach, CA 90802.
    Contact Person: Khalid Masood, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5120, MSC 7854, Bethesda, MD 20892, 301-435-
2392, masoodk@csr.nih.gov.

    Name of Committee: Cell Biology Integrated Review Group; 
Development--2 Study Section.
    Date: June 2-3, 2014.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Renaissance Long Beach Hotel, 111 East Ocean Blvd., Long 
Beach, CA 90802.
    Contact Person: Rass M Shayiq, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institute of Health, 6701 
Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD 20892, (301) 435-
2359, shayiqr@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Psychosocial Risk and Disease Prevention.
    Date: June 2, 2014.
    Time: 11:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 25136]]

    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Kristen Prentice, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3112, MSC 7808, Bethesda, MD 
20892, 301-496-0726, prenticekj@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: April 28, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-10016 Filed 5-1-14; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.